Page 223 - Programme book for The International Liver Congress 2015, EASL ILC 2015

TOP 10% EVOLUTIONARY CHANGES OF HEPATITIS B VIRUS ePOSTERS
YI P0604 PRE-S MUTATIONS PRIOR TO DEVELOPMENT OF
TOP 10% HEPATOCELLULAR CARCINOMA
YI P0605 Anye Zhang*, Danny Ka-Ho Wong, Fung-Yu Huang, Wai-Kay Seto,
James Fung, Ching-Lung Lai, Man-Fung Yuen, Hong Kong, China
YI P0606
YI P0607 GENOTYPE SPECIFIC VARIATION IN THE BASAL CORE
PROMOTER AND PRE CORE REGIONS IMPACTS HBEAG
YI P0608 LEVELS DURING IMMUNE CLEARANCE DISEASE
YI P0609 Julianne Bayliss*, Gillian Rosenberg, Alexander Thompson, Anuj Gaggar,
Kathryn Kitrinos, Mani Subramanian, Patrick Marcellin, Edward Gane,
Henry L. Chan, Xin Li, Danni Colledge, Lilly Yuen, Margaret Littlejohn,
Rosalind Edwards, Kathleen Jackson, Sara Bonanzinga,
Rachel Hammond, Scott Bowden, Stephen Locarnini, Peter Revill,
Australia

TNF-ALPHA SIGNIFICANTLY INHIBITS HEPATITIS E VIRUS
REPLICATION
Patrick Behrendt*, Svenja Drave, Sven Pischke, Heiner Wedemeyer,
Eike Steinmann, Germany

PREVENTION OF VERTICAL TRANSMISSION OF
HEPATITIS B: AN EVALUATION OF ADHERENCE
RATES AND RISK FACTORS FOR FAILURE TO PROVIDE
IMMUNOPROPHYLAXIS THERAPY IN A SINGLE
AUSTRALIAN CENTRE
Lukas Sahhar*, Stephanie Spring, Phil Ha, Natassia Tan, Vanessa Bull,
William Birkett, Emily Lickliter, Joseph Lewis, Trushna Trivedi,
Suong Le, Anouk Dev, Australia

CAN MBL2 GENOTYPES AND ITS POLYMORPHISM
PREDICT THE OCCURRENCE OF CIRRHOSIS AND
HEPATOCELLULAR CARCINOMA?
Rajesh Ruttala*, Vijay K. Karra, Sunil K. Polipalli, Arvind Rai,
Premashis Kar, India

RISK PREDICTION OF NON-CIRRHOTIC
HEPATOCELLULAR CARCINOMA IN PATIENTS WITH
CHRONIC HEPATITIS B VIRUS INFECTION
Wen-Juei Jeng*, Hwai-I Yang, Jessica Liu, Mei-Hsuan Lee, Chin-Lan Jen,
Richard Batrla-Utermann, Sheng-Nan Lu, Li-Yu Wang, San-Lin You, Chien-
Jen Chen, Taiwan

Vienna, Austria • April 22–26, 2015 223